Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/08/13 → 31/01/15 |
Funding
- SignPath Pharmaceuticals, Inc.: $153,599.00
Keywords
- Biotechnology & Drug Development, Cancer Research, Nanotechnology
Studies with Curcumin ER
- Vishwanatha, Jamboor (PI)
- Ranjan, Amalendu (CoI)